7781 - 7790 of 8818 Results
Title
Year
-
OPENTitle: Fully automatic categorical analysis of striatal subregions in dopamine transporter SPECT using a convolutional neural networkJournal Name: Annals of Nuclear MedicinePublisher: Springer Science and Business Media LLCVol: 39Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12149-025-02038-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12149-025-02038-3.pdfCitation Count: 0
-
OPENTitle: A Novel α‐Synuclein K58N Missense Variant in a Patient with Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.70030Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70030Citation Count: 0
-
OPENTitle: Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuumJournal Name: NeuronPublisher: Elsevier BVVol: 113Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuron.2025.02.014Citation Count: 2
-
OPENTitle: Safety and Feasibility of Serial Lumbar Punctures: Long-term Results from the Parkinson’s Progression Markers InitiativeJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 13Issue #:Start Page: 100385End Page: 100385Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100385Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100385Citation Count: 0
-
OPENTitle: Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s diseaseJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 56Issue #: 12Start Page: 2672End Page: 2684Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41588-024-01972-8Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10275048Citation Count: 22
-
OPENTitle: A blood-based DNA damage signature in patients with Parkinson’s disease is associated with disease progressionJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 5Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s43587-025-00926-xBest OA location URL: https://www.nature.com/articles/s43587-025-00926-x.pdfCitation Count: 0
-
RESTRICTEDTitle: Associations between neuropsychiatric symptoms and pathology in clinicopathologically defined Alzheimer's disease, Alzheimer's disease with Lewy bodies, and dementia with Lewy bodiesJournal Name: Journal of Alzheimer’s DiseasePublisher: SAGE PublicationsVol: 104Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/13872877251320670Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/13872877251320670Citation Count: 0
-
OPENTitle: The Exon-Based Transcriptomic Analysis of Parkinson’s DiseaseJournal Name: BiomoleculesPublisher: MDPI AGVol: 15Issue #: 3Start Page: 440End Page: 440Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom15030440Best OA location URL: https://www.mdpi.com/2218-273X/15/3/440/pdf?version=1742387431Citation Count: 0
-
OPENTitle: Clinical and functional evidence for the pathogenicity of the LRRK2 p.Arg1067Gln variantJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00884-6Best OA location URL: https://www.nature.com/articles/s41531-025-00884-6.pdfCitation Count: 1
-
OPENTitle: Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 9Start Page: 2631End Page: 2640Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-03101-8Best OA location URL: https://www.nature.com/articles/s41591-024-03101-8.pdfCitation Count: 11